Streetbeat News

PXMD

PaxMedica Inc

Employees

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

In Friday's after-market session, several healthcare stocks showed notable movements. Qilian Intl Hldg Gr (QLI) led the gainers with a 50.4% increase, while PaxMedica (PXMD) experienced the largest decline among the losers, dropping 8%. Other notable movers included Allarity Therapeutics (ALLR) and Cormedix (CRMD) with significant gains, and OncoCyte (OCX) which declined following its Q4 earnings release.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:31 pm

Nasdaq fell 300 points as U.S. stocks traded lower, with BlackRock posting upbeat earnings. Utilities and materials sectors saw declines, while specific companies like PaxMedica, EZGO Technologies, and NextPlat reported significant stock movements. Conversely, Motus GI Holdings, JPMorgan Chase, and Applied Digital Corporation experienced notable drops. The article also covers commodity prices, European and Asian market performances, and U.S. economic indicators.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 7:00 pm

JPMorgan Chase & Co. shares fell by 5.1% despite beating first-quarter earnings and revenue expectations, with other stocks experiencing significant movements in Friday's mid-day session. Notable gainers include PaxMedica, EZGO Technologies, and Allarity Therapeutics, among others, with various reasons for their stock movements. Conversely, several companies faced declines, such as Motus GI Holdings, Lixiang Education, and Monogram Orthopaedics, each with specific challenges impacting their stock prices.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 6:47 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. PaxMedica (PXMD) led the gainers with a 110.9% increase, while Motus GI Holdings (MOTS) saw the largest decline at 39%. Other notable movers include Q32 Bio (QTTB), Cyclacel Pharmaceuticals (CYCCP), and Rani Therapeutics Holdings (RANI) among the gainers, and Monogram Orthopaedics (MGRM) and BioSig Technologies (BSGM) among the losers.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:31 pm

PaxMedica (PXMD) shares surged 171% after announcing the completion of pivotal batches of PAX-101. NextPlat (NXPL) shares rose 98% with an increase in FY23 revenue. Globe Life (GL) shares increased 14% despite a short report from Fuzzy Panda Research, which the company refuted.

Portfolio Pulse from ryanfaloona@benzinga.com

April 12, 2024 | 12:43 pm

In Friday's pre-market session, several healthcare stocks showed significant movement. PaxMedica led the gainers with a 104.2% increase, while Motus GI Holdings experienced the largest drop among the losers, falling 26.1%. The movements reflect notable volatility in the healthcare sector, with companies ranging from biotech to pharmaceuticals experiencing shifts in their stock prices.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 12:09 pm

PaxMedica (PXMD) shares surged following the announcement of the successful completion of three pivotal registration/validation batches of PAX-101, signaling significant progress in the drug's development pathway.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 11:10 am

NextPlat Corp (NASDAQ:NXPL) shares surged approximately 30% in pre-market trading after announcing a 222% year-over-year increase in consolidated 2023 revenues, reaching $37.8 million. Other stocks also showed significant movement in pre-market trading, with notable gainers including Allarity Therapeutics, PaxMedica, OncoCyte Corporation, and Zapata Computing Holdings, among others. Conversely, several stocks experienced declines, such as Motus GI Holdings, Rent the Runway, and Kazia Therapeutics, driven by various company-specific news and market reactions.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 9:32 am

Citigroup, JPMorgan, Argan, PaxMedica, and Wells Fargo are stocks to watch due to earnings reports and significant after-hours trading movements. Citigroup and Wells Fargo are anticipated to report their quarterly earnings, with Citigroup expected to show a decrease compared to the previous year. Argan reported better-than-expected Q4 results, leading to a 7.4% increase in its stock price. JPMorgan is also expected to release its earnings, with a slight increase in its stock price in after-hours trading. PaxMedica announced the completion of pivotal batches for PAX-101, causing a 116.1% surge in its stock price.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 7:00 am

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 8:34 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.